Ryuichi Ogawa

Summary

Affiliation: Meiji Pharmaceutical University
Country: Japan

Publications

  1. ncbi request reprint Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously)
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, 2 522 1 Noshio, Kiyose, Tokyo 204 0004, Japan
    Clin Pharmacokinet 52:169-85. 2013
  2. ncbi request reprint A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese
    R Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose shi, Tokyo, 204 8588, Japan
    Int J Clin Pharmacol Ther 48:109-19. 2010
  3. doi request reprint Drug-drug interaction profiles of proton pump inhibitors
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan
    Clin Pharmacokinet 49:509-33. 2010
  4. doi request reprint Clinically significant drug interactions with antacids: an update
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan
    Drugs 71:1839-64. 2011
  5. doi request reprint Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan my pharm ac jp
    Int J Clin Pharmacol Ther 51:357-66. 2013
  6. ncbi request reprint [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis]
    Keiko Ohno
    Department of Medication Use Analysis, Meiji Pharmaceutical University, Noshio, Kiyose, Tokyo, Japan
    Yakugaku Zasshi 124:555-60. 2004
  7. ncbi request reprint Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, 2 522 1 Noshio, Kiyose, Tokyo 204 8588, Japan
    J Clin Pharmacol 46:59-68. 2006
  8. ncbi request reprint Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty
    Naoko Kamiyama
    Course of Clinical Pharmacy, Graduate School of Pharmaceutical Science, Meiji Pharmaceutical University, 2 522 1 Noshio, Kiyose City, Tokyo, Japan
    Yakugaku Zasshi 128:1333-9. 2008

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously)
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, 2 522 1 Noshio, Kiyose, Tokyo 204 0004, Japan
    Clin Pharmacokinet 52:169-85. 2013
    ..Because there is a paucity of information regarding the pharmacokinetics of drugs in patients with severe heart failure, close attention should be paid to monitoring the efficacy of these agents and their associated adverse effects...
  2. ncbi request reprint A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese
    R Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose shi, Tokyo, 204 8588, Japan
    Int J Clin Pharmacol Ther 48:109-19. 2010
    ..We aimed to study whether mutations in the beta-subunits of sodium channel (SCN1B and SCN2B) would also be associated with abnormal cardiac excitation in BrS...
  3. doi request reprint Drug-drug interaction profiles of proton pump inhibitors
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan
    Clin Pharmacokinet 49:509-33. 2010
    ..Further studies are urgently required to clarify the mechanism of this DDI and to explore new aspects of the DDI potential of PPIs...
  4. doi request reprint Clinically significant drug interactions with antacids: an update
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan
    Drugs 71:1839-64. 2011
    ..e. a gastric pH-dependent mechanism by H2RAs and a cation-mediated chelation mechanism by antacids...
  5. doi request reprint Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan my pharm ac jp
    Int J Clin Pharmacol Ther 51:357-66. 2013
    ..This study aimed to assess whether this regimen was appropriate based on the pharmacokinetic/pharmacodynamic (PK/PD) analyses in Japanese patients...
  6. ncbi request reprint [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis]
    Keiko Ohno
    Department of Medication Use Analysis, Meiji Pharmaceutical University, Noshio, Kiyose, Tokyo, Japan
    Yakugaku Zasshi 124:555-60. 2004
    ..11 (95% CI: 0.92 to 4.84). From the viewpoint of effectiveness and safety, this meta-analysis suggests that AZA might be useful in the maintenance of remission in UC patients...
  7. ncbi request reprint Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias
    Ryuichi Ogawa
    Department of Pharmacotherapy, Meiji Pharmaceutical University, 2 522 1 Noshio, Kiyose, Tokyo 204 8588, Japan
    J Clin Pharmacol 46:59-68. 2006
    ..In conclusion, female gender, renal dysfunction, and the drug-induced BrS-like ECG morphology may be associated with augmented ECG responses to pilsicainide...
  8. ncbi request reprint Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty
    Naoko Kamiyama
    Course of Clinical Pharmacy, Graduate School of Pharmaceutical Science, Meiji Pharmaceutical University, 2 522 1 Noshio, Kiyose City, Tokyo, Japan
    Yakugaku Zasshi 128:1333-9. 2008
    ..In addition, this finding suggests that a larger dose of NAC results in a lower Scr value, we consider that the NAC dosage more likely prevented CIN...